While scientific innovation is propelling healthcare into the future, there remains a distinct gap between technologies that make it to market and those that are relegated to early-stage failures. Those innovations that never make it to patients are sometimes the most promising, so why didn’t they […]
Share Your Story About High Drug Prices
At his State of the Union Address last week, President Biden shared the story of a family struggling to pay for the life-saving insulin they depend on. Patients for Affordable Drugs, an independent national patient organization dedicated to lowering drug prices, wants to hear your story. In doing […]
How to Bring Patients Back to their PCPs
CDC data from June 2020 shows a striking 41% of adults delayed medical care. In the time since, this avoidance has become a growing issue, compromising care for chronic and common health conditions and contributing to decreasing life expectancy. In a new Managed Healthcare Executive article, Marc […]
Medicare Patients Anticipate Troubles Affording Healthcare in 2022
A new survey from MedicalCares.com shows that 60% of Medicare recipients predict they’ll have trouble paying for their healthcare in the upcoming year. This comes after a 14.5% hike in monthly premiums from 2021 to 2022, attributed to the pause on Medicare price increases due to the CARES act and […]
AMA Podcast: Health IT Shifts from a Hassle to Essential Tool for Improving Care
Despite a track record of frustration for patients and providers, healthcare technology has evolved during the pandemic into a crucial tool to improve patient care, according to an episode of the American Medical Association’s podcast, “Making the Rounds.” One example has been the meteoric rise of […]
Interview: David Kim Talks about the Tufts Cost-Effectiveness Analyzer (CEA) Registry
Assistant professor David Kim speaks with Rachel Breslau about his role as program director of the Tufts cost-effectiveness analyzer (CEA) registry in a new Center for the Evaluation of Value and Risk in Health (CEVR) interview. In the interview, Kim speaks about his path into the health economic […]
Cost-Sharing has Unforeseen Consequences for Patients and Payers
Cost-sharing measures like co-pays, deductibles, and co-insurance are ostensibly intended to help reduce payer costs and have patients take ownership of their care and make responsible treatment decisions. However, this information is not well-conveyed to patients and often results in patients not […]
JAMA Network Open Article Highlights the Plight of the Uninsured as Drug Costs Soar
A recent article published in JAMA Network Open highlights one major healthcare spending trend: the uninsured. An increase in concentration of spending on prescription drugs is growing and could result in widespread consequences. “The Patient Protection and Affordable Care Act has been associated […]
RWD Advances Rare Disease R&D, Brings Hope to Patients
Patient registries are fast becoming a critical source of real world data (RWD), especially in rare disease research and development (R&D). A recent article discusses the acceleration in orphan drug approvals and the benefits of the STATinMED RWD Insights tool. “Rare diseases are not so […]
AllStripes Announces $50 Million in Series B Funding to Advance Rare Disease Research
AllStripes has raised $50 million in Series B Funding, led by Lux Capital. As a result, the organization has initiated more than 100 programs to investigate rare diseases and to improve patient outcomes. AllStripes CEO and Co-Founder Nancy Yu remarks, “Beginning research on a rare condition can […]
